TrumpRx expands with 2 new drug makers offering prescription discounts

TrumpRx expands with 2 new drug makers offering prescription discounts


EXCLUSIVE: The White House is anticipating to announce an enlargement of drugmakers offering discounts on TrumpRx.gov, FOX Business has discovered.

As early as at the moment, Amgen and GSK will probably be added to the listing of prescription drug producers offering discounts on the federal government web site. That makes a complete of 54 prescription medicines from six pharmaceutical firms which have signed on to the most-favored-nation pricing underneath strain from President donald trump and the specter of tariffs.

Amgen will provide treatment on the web site that cuts 80% off the retail worth. Amjevita has an authentic worth of $1,484, however will probably be accessible on TrumpRx.gov for $299. The treatment treats rheumatoid arthritis, psoriasis and ulcerative colitis.

FOX NEWS POLL: VOTERS SOUND ALARM ON HEALTHCARE COSTS

President Donald Trump speaks as Administrator for the Centers for Medicare & Medicaid Services Mehmet Oz appears to be like on throughout an occasion on drug pricing within the South Court Auditorium on the White House campus Feb. 5, 2026, in Washington, DC (Nathan Howard/Getty Images)

The firm plans to listing Aimovig and Repatha for discounts of 62%.

GSK will low cost Incruse at 55% of the retail worth. The drug treats COPD and will probably be listed at $159.

GSK additionally plans to listing Arnuity, Relenza and Anoro at discounts starting from 10% to 51%.

TickerSecurityLastchangeChange %
AMGNAMGEN INC.366.21-1.58

-0.43%

GSKGSK PLC53.39-0.89

-1.64%

“GSK and Amgen connecting with TrumpRx.gov to offer prescription drugs directly to consumers at most-favored-nations pricing marks another milestone for President Trump’s affordability push,” White House spokesperson Kush Desai informed FOX Business.

“TrumpRx.gov is just the beginning, however, as Americans are set to (receive) even greater drug pricing discounts, lower insurance premiums and more transparency when Congress passes President Trump’s Great Healthcare Plan.”

A pharmacy tech pulls medication from a shelf inside a pharmacy

Amgen will provide treatment on the web site that cuts 80% off the retail worth. (George Frey/Bloomberg through Getty Images)

The Pharmaceutical Research and Manufacturers of America represents main drug firms.

CEO Stephen Ubl believes “Government-imposed most-favored-nation insurance policies would undermine US competitiveness whereas doing nothing to deal with insurance coverage practices that deny care and lift prices for sufferers.

HOUSE GOP SEEKS OFF-RAMP TO SKY-HIGH HEALTH INSURANCE COSTS FOR MILLIONS OF AMERICANS

“These insurance policies would siphon billions from American R&D, gradual the tempo of cures and enhance reliance on China for future innovation.”

(*2*)An image of medication at a Walgreens pharmacy.

GSK will discount Incruse at 55% of the retail price. (Jeffrey Greenberg/Universal Images Group via Getty Images)

The White House is pushing ahead with announcements to TrumpRx.gov as Americans look for ways to cut medical costs.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Under the Biden administration, Bureau of Labor Statistics knowledge reveals, prescription drug prices elevated 10.4% from January 2021 to January 2025. Under the Trump administration, prescription drug costs elevated 0.2% from January 2025 via the most recent knowledge from February 2026.

Leave a Reply

Your email address will not be published. Required fields are marked *